Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL28290435

CC(C)(C)OC=O.c1ncc(CN2CCNCC2)s1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
SLC6A4 P31645 3/20 0.38
SLC6A2 P23975 2/20 0.38
JAK2 O60674 2/20 0.36
JAK1 P23458 2/20 0.36
TYK2 P29597 2/20 0.36
JAK3 P52333 2/20 0.36
NMT1 P30419 1/20 0.36
SRPK1 Q96SB4 2/20 0.34
SIGMAR1 Q99720 1/20 0.33
LTA4H P09960 1/20 0.33
TLR9 Q9NR96 1/20 0.33
TLR8 Q9NR97 1/20 0.33
TLR7 Q9NYK1 1/20 0.33
OPRD1 P41143 2/20 0.33
CYP1A2 P05177 1/20 0.33
CHRM2 P08172 1/20 0.33
OPRK1 P41145 1/20 0.33
LMNA P02545 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL207529 0.83 ALDH1A1 (0.47) ALDH1A1SLC6A4SLC6A2JAK2JAK1
Tert-Butyl Formate SCHEMBL28289206 0.79 SIGMAR1 (0.42) SLC6A4SIGMAR1OPRD1CYP1A2CHRM2
Tert-Butyl Formate SCHEMBL27844700 0.77 HPGD (0.51) ALDH1A1SIGMAR1CYP1A2CHRM2
Tert-Butyl Formate SCHEMBL28289066 0.76 KDM5C (0.43) ALDH1A1SRPK1SIGMAR1
Tert-Butyl Formate SCHEMBL27844848 0.76 CHRNB2 (0.52) ALDH1A1SIGMAR1
Tert-Butyl Formate SCHEMBL28872040 0.76 ALOX15 (0.53) ALDH1A1SLC6A4SLC6A2CYP1A2
Tert-Butyl Formate SCHEMBL28289062 0.76 KDM5C (0.38) JAK2JAK1JAK3NMT1SRPK1
Tert-Butyl Formate SCHEMBL28305079 0.74 KDM5C (0.39) ALDH1A1SLC6A4SIGMAR1TLR9TLR8
Tert-Butyl Formate SCHEMBL27524789 0.74 SIGMAR1 (0.66) ALDH1A1SIGMAR1CHRM2LMNA
Tert-Butyl Formate SCHEMBL27993846 0.73 CXCR4 (0.48) ALDH1A1SIGMAR1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563092-A It can be used as the 2- phenylimidazole of the active inhibitor of mammal tyrosine kinase ROR1 simultaneously [4,5-B] pyridine -7- amine derivative 坎塞拉有限公司 2019-04-02 CN disclosed